Background And Objective: Gurami Sago Osphronemus goramy (O. goramy) are an herbivorous freshwater finfish species native in Indonesia. This species has not yet been cultured commercially in brackish water. A 60-days study was conducted to evaluate the effects of salinity on survival and growth of O. goramy.

Materials And Methods: Two independent experiments were performed to determine the effects of salinity on survival and growth of juvenile O. goramy, first one was to determine the median lethal salinity (MLS-5096 h) and second one was to assess the survival and growth at different sub-lethal salinities. In MLS-5096 h study 0.0, 4.0, 8.0, 12.0 and 16.0 ppt salinities were used to initially find out the salinity tolerance range. Accordingly, a definitive salinity tolerance test was done in next phase to find out exact median lethal salinity by directly transferring the test species to 13.0, 14.0, 15.0 and 16.0 ppt salinity for 96 h. The median lethal salinity of O. goramy was estimated at 14.0 ppt. In the second experiment, survival and growth of the O. goramy were recorded at salinities 4.0, 8.0 and 12.0 ppt along with 0.0 ppt as control during 60 days.

Results: Osigni goramy exhibited lowest final average weight at 12.0 ppt salinity and significantly highest at 4.0 ppt salinity. Highest SGR and weight gain were obtained at 4.0 ppt followed by 0 ppt, 8 ppt and 12 ppt salinity. All treatments were significantly (p<0.05). Survival rate of O. goramy varied between 76.45% (at 0.0 ppt) and 66.66% (at 12.0 ppt).

Conclusion: The O. goramy grew and survived satisfactorily at 0.0 to12.0 ppt salinities, implying that the species can be cultured commercially in brackish water, in view of in Indonesia, there are many abandoned shrimp ponds.

Download full-text PDF

Source
http://dx.doi.org/10.3923/pjbs.2018.171.178DOI Listing

Publication Analysis

Top Keywords

survival growth
20
ppt salinity
16
ppt ppt
16
effects salinity
12
salinity survival
12
median lethal
12
lethal salinity
12
salinity
11
ppt
11
gurami sago
8

Similar Publications

Importance: Cardiovascular disease (CVD) and cancer are the leading causes of mortality in the US. Large-scale population-based and mechanistic studies support a direct effect of CVD on accelerated tumor growth and spread, specifically in breast cancer.

Objective: To assess whether individuals presenting with advanced breast cancers are more likely to have prevalent CVD compared with those with early-stage breast cancers at the time of diagnosis.

View Article and Find Full Text PDF

is a foodborne pathogen linked to severe infections in infants and often associated with contaminated powdered infant formula. The RecA protein, a key player in DNA repair and recombination, also influences bacterial resilience and virulence. This study investigated the impact of deletion on the pathogenicity and environmental stress tolerance of BAA-894.

View Article and Find Full Text PDF

Protein kinase R (PKR) is an interferon-induced antiviral protein activated by autophosphorylation in response to double strand DNA (dsRNA) and other stimuli. Activated PKR causes translation inhibition and apoptosis, and it contributes to proinflammatory responses, cell growth, and differentiation. Mouse adenovirus type 1 (MAV-1) counteracts PKR by causing its degradation via a viral protein, early region 4 open reading frame 6 (E4orf6).

View Article and Find Full Text PDF

Unlabelled: RamA is an intrinsic regulator in , belonging to the AraC family of transcription factors and conferring a multidrug resistance phenotype, especially for tetracycline-class antibiotics. The ATP-binding cassette transporters MlaFEDCB in bacteria play essential roles in functions essential for cell survival and intrinsic resistance to many antibiotics. We found deletion of resulted in a fivefold decrease in the transcriptional levels of the operon.

View Article and Find Full Text PDF

Pulmonary vascular remodeling and arterial hypertension (PAH) correlate to increased platelet-derived growth factor (PDGF) activity and elevated KIT expression. Imatinib has emerged as a potential therapeutic agent for PAH. The purpose of this systematic review and meta-analysis was to assess the effectiveness of imatinib in treatment of PAH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!